HLB Life Science has ranked among the top searched stocks for 8 days in the past month.
As of 12:30 PM on the 23rd, HLB Life Science is trading at 30,300 KRW, down 0.33% from the previous day. This represents a 73.64% increase compared to August 27. HLB Life Science is known as an engineering service company related to energy saving.
Today, foreigners have net purchased 50,000 shares of HLB Life Science, and institutions have net purchased 2,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 2,352 shares, while foreigners and institutions have net purchased 62,694 shares and net sold 51,027 shares, respectively.
On September 21, HLB Life Science became a market issue with a 21% increase following the Phase 3 clinical trial results of ‘Riboceranib’.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
